Average Co-Inventor Count = 5.71
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,076 patents)
2. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)
3. Washington University (1 from 1,579 patents)
4. Convergene, LLC (5 patents)
12 patents:
1. 11426415 - Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders
2. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
3. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
4. 10662170 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
5. 10214493 - Indazole derivatives useful as glucagon receptor antagonists
6. 10131648 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
7. 10000473 - Indazole derivatives useful as glucagon receptor antagonists
8. 9790198 - Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
9. 9238658 - Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
10. 9102669 - Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors
11. 8748624 - Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
12. 7803793 - Heterocyclic derived metalloprotease inhibitors